Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries

Giuseppe Ambrosio1, Luis Henrique Wolff Gowdak2, Richard B Weiskopf3

  • 1National Institute for Cardiovascular Research - INRC, Bologna, Italy.

Insights

Ischemic heart disease (IHD) guidelines are less applicable in low- and middle-income countries (LMIC) due to cost and relevance. Future guidelines need LMIC input and cost considerations for global health equity.

Area of Science:

  • Cardiology
  • Global Health
  • Health Policy

Background:

  • Ischemic heart disease (IHD) poses a significant global health challenge.
  • Current clinical practice guidelines for IHD are often developed in high-income countries (HIC), potentially overlooking implementation barriers in low- and middle-income countries (LMIC).

Purpose of the Study:

  • To assess clinicians' use of IHD guidelines.
  • To identify perceived deficiencies and implementation barriers of IHD guidelines.
  • To compare guideline applicability between HIC and LMIC settings.

Main Methods:

  • An international, internet-based survey of physicians treating IHD patients.
  • Data collected on demographics, experience, and views on IHD guideline applicability.
  • Survey conducted from July 26, 2025, to November 15, 2025.

Main Results:

  • 587 clinicians from 97 countries responded.
  • Only 51.8% found IHD guidelines applicable, with lower rates in LMIC (48.8%) vs. HIC (67.3%).
  • Major barriers included guideline relevance to HIC (72%) and cost, particularly for LMIC (61.7%).

Conclusions:

  • Current IHD guidelines inadequately address the needs of clinicians and patients in LMIC.
  • Future guidelines should include LMIC-specific recommendations and consider cost reimbursement.
  • Digital formats and LMIC co-authorship were desired for future guidelines.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...